baber/WOPTO huggingface dataset:
Patent AT-E148205-T1 (AT)
Inventor: FLAIG CHRISTIAN
IPC: F16B39/38
Filed: 1994-04-18
Granted: 1997-02-15
Abstract: The nut has a locking portion concentric and adjacent to the tapped bore, and an elastic locking member secured in the axial direction in a neck on the nut, with which it is in frictional contact. This consists of a washer of thickness matching the thread pitch in the nut, and fitting in an annular groove in the neck. Its inside edge is tapped with the same thread as the nut but slightly offset in relation to the latter in the axial direction. Three symmetrical flats (28a,b,c) are formed in the outside edge of the washer. Notches (32a,b,c) are formed in the outside edge sections (30a,b,c) between the flats on the washer (10), their depth (t) in the radial direction being equal to or less than the max. depth of the flats in the same direction.
Patent AT-E153685-T1 (AT)
Inventor: WEBER WILHELM DR
IPC: C09K3/10
Filed: 1994-04-20
Granted: 1997-06-15
Abstract: The invention relates to a process for improving the shelf life (storage stability) of one-component silicone pastes which cure on contact with atmospheric moisture with elimination of acetic acid.
Patent AT-E151347-T1 (AT)
Inventor: MUELLER JOACHIM
IPC: B41F31/02
Filed: 1994-11-18
Granted: 1997-04-15
Abstract: A method for supplying printing ink in the vibrating inking unit of a printing machine, in which the supply takes place transversely relative to the printing direction in a zonally varying manner in each case by adjusting a film thickness gradient of the printing ink directed towards the printing forme, is to be improved in such a way that, especially in the case of a small proportion of the surface of the printing forme to be printed, the fewest possible balancing sheets in relation to a steady-state inking level can be achieved relative to the next steady-state inking level. According to the invention, this is achieved in that, in at least one zone and at least for a specific duration, a delivery of printing ink takes place by adjusting a film thickness gradient directed in the opposite direction. This can be achieved, for example, in that no supply of printing ink takes place in specific zones and the return flow of ink present in these zones is balanced by an increased supply of printing ink in other zones with a correspondingly steeper film thickness gradient.
Patent AT-E191010-T1 (AT)
Inventor: YAMAUCHI TADAKAZU
IPC: C07C215/16
Filed: 1994-12-29
Granted: 2000-04-15
Abstract: An enzyme electrode, specific binding or the like electrochemical assay method capable of performing always stably high detection sensitivity (responsibility) and reappearance even in the case of blood, urine and the like samples that contain interfering substances and also of applying suitably to disposable use, and a novel p-phenylenediamine compound which is used in the assay method. Particularly, an electrochemical assay method in which a substance in a liquid sample is assayed using at least one oxidoreductase, wherein an oxidoreductase, an electron mediator and an electrode which performs electron transfer with the mediator are arranged in the assay system, and a compound of the following formula [I] or a salt thereof is used as the mediator which is highly soluble in water, dried (by freeze-, vacuum- or air-drying) easily and stable under dry condition, shows a high electron transfer rate with enzymes and is almost free from the influence of interfering substances in blood, urine and the like samples: <CHEM> wherein R<1> to R<4> may be the same or different from one another and each means a hydrogen, a straight- or branched-chain alkyl group having 1 to 4 carbon atoms, optionally having a substituent, providing that at least one of R<1> to R<4> has one or more groups selected from hydroxyl, mercapto, carboxyl, phosphonooxy and sulfo. <IMAGE>
Patent AT-E198426-T1 (AT)
Inventor: ZARDI UMBERTO
IPC: B01J8/04
Filed: 1994-10-12
Granted: 2001-01-15
Abstract: In a method of modernizing a heterogeneous exothermic synthesis reactor (1) of the type comprising an external shell (2), in which at least one catalytic bed (15, 16, 17) is supported, the catalytic bed (15, 16, 17) is connected to an external boiler (21), for generating high pressure steam, by means of a reacted gas outlet nozzle (4) and a conduit (29) extending in said nozzle (4) thereby forming an annular airspace (30). Advantageously, the airspace (30) defines an outlet flowpath of the gases cooled in the boiler (21) which avoids overheating of the nozzle (4). <IMAGE>
Patent AT-E146850-T1 (AT)
Inventor: FREDERIKSEN EYVIND
IPC: F01N1/06
Filed: 1994-01-31
Granted: 1997-01-15
Abstract: A silencer, preferably for exhaust gases from internal combustion engines, consisting of a container having a shell (1) formed essentially as a cylinder face, and two end bottoms (2, 3) as well as at least one admission pipe (4) and one discharge pipe (5) for exhaust gas, wherein the flow prior to entering the internal volume of the container is converted to a slot flow between an outer plate (6) and an inner plate (8), said plates being so shaped at their periphery as to form an exhaust gas discharge opening (14), which is positioned radially substantially symmetrically around the pressure node of a transverse oscillation in the container, said plates (6, 8) having a contour direction at the discharge opening (14) which is substantially perpendicular to the radial direction. Improved damping of transverse oscillations in the chamber of the silencer is hereby obtained by simple means.
Patent AT-E221575-T1 (AT)
Inventor: WILSON JAMES M
IPC: C12N15/09
Filed: 1994-05-10
Granted: 2002-08-15
Abstract: The present invention relates to methods for selective somatic gene transfer into a patient's pancreatic or biliary epithelial cells. The methods of this invention comprise introducing the gene to be transferred, associated with an appropriate transfer vehicle, into the ductal system of either the pancreas or liver. More specifically, the invention relates to using these techniques to, treat genetic disease, such as cystic fibrosis, which are characterized by genetic defects in those epithelial cells. <IMAGE>
Patent AT-E153976-T1 (AT)
Inventor: PADOVANI PIETRO
IPC: B65G47/90
Filed: 1993-12-27
Granted: 1997-06-15
Abstract: A pick-up and transfer head (1) for hollow objects (10) which is particularly suitable for picking up thermoformed objects from a female die (3) and transferring them to a receiving station (22) in a thermoforming apparatus, which comprises at least one pick-up structure (1) which is designed to engage and support the object (10) or objects to be picked up and transfer them to a supporting and displacement unit (22), and has a flat plate-like (4) or reticular member having at least one seat (5) for the respective object (10) or objects to be picked up and transferred, engaging/disengaging means (6) for the corresponding object (10) located at seat (5) or seats and control means for the said engaging/disengaging means (6) to control the picking-up and release of the object (10) or objects.
Patent AT-E244012-T1 (AT)
Inventor: HORSTMANN MICHAEL
IPC: A61K9/70
Filed: 1994-09-16
Granted: 2003-07-15
Abstract: PCT No. PCT/EP94/03106 Sec. 371 Date Jul. 15, 1996 Sec. 102(e) Date Jul. 15, 1996 PCT Filed Sep. 16, 1994 PCT Pub. No. WO95/08330 PCT Pub. Date Mar. 30, 1995Transdermal therapeutic system comprising the active substance acetylsalicylic acid, having a layered structure consisting of a backing layer which is substantially impermeable to active substances and moisture and one or several active substance-containing matrix layers, which is characterized in that at least one of said matrix layers comprises acetylsalicylic acid in mainly crystalline form.
Patent AT-E167228-T1 (AT)
Inventor: VASSILAKIS DESPINA
IPC: C10L1/18
Filed: 1994-09-29
Granted: 1998-06-15
Abstract: PCT No. PCT/FR94/01138 Sec. 371 Date Aug. 13, 1996 Sec. 102(e) Date Aug. 13, 1996 PCT Filed Sep. 29, 1994 PCT Pub. No. WO95/09220 PCT Pub. Date Apr. 6, 1995Additive composition enhancing the low temperature operability of average distillates beyond -20 DEG  C. comprising at least 40% by weight of a composition consisting of: i) from 60 to 94% by weight of an antisedimentation additive resulting from the reaction of at least one aliphatic dicarboxylic compound and one polyamine of general formula (II) wherein R is a saturated aliphatic radical comprising from 1 to 32 carbon atoms, n is 2-4 and m is 1-4; and ii) 6-40 % by weight of a dispersing-stabilizing additive having a molecular weight varying from 15000 to 50000 resulting from the esterification reaction of a linear alcohol having from 6 to 24 atoms with an organic acid such as maleic acid and its halides, the ester obtained being polymerized with itself or a copolymerizing compound selected from aliphatic dicarboxylic compounds.
Patent AT-E160047-T1 (AT)
Inventor: FRANZ HERBERT DIPL ING
IPC: H01H3/20
Filed: 1995-08-10
Granted: 1997-11-15
Abstract: The switch latch is provided by a locking button (17) operated to secure the hollow push-button head (14) in a defined switch position, within the switch housing (11), against a return spring bias. The hollow interior of the push-button head has retaining profiles (16) on opposing sides, with the locking button coupled to a forked slider (20), displaced by the locking button to bring the ends (26) of the forks, which projecting into the push-button head from below, into engagement with the retaining profiles. Pref. the ends of the forks have stop surfaces (27, 28) for retaining profiles.
Patent AT-E192585-T1 (AT)
Inventor: STEINHARDT LOTHAR DIPL-ING
IPC: G05D7/01
Filed: 1995-09-30
Granted: 2000-05-15
Abstract: A liquid container (22) has an outlet in the base that is variable to maintain a constant delivery flow rate when the level (H) of fluid in the container changes. The control device is immersed in the fluid and consists of a bellows element (2) that axially expands and contracts as the level changes. The internal volume of the bellows is vented through a pipe (4). The top of the bellows is attached to a gate valve element (3) that controls the outflow rate. The bellows responds to the different between the force due to the static fluid head and the force provided by a spring within the bellows. An increase in level causes a reduction in outlet area and a decrease produces an increase in area.
Patent AT-E177765-T1 (AT)
Inventor: ABUSLEME JULIO A
IPC: C08F10/00
Filed: 1995-12-29
Granted: 1999-04-15
Abstract: Copolymers comprising:     (A) from 30 to 70% by moles of ethylene; (B) from 30 to 70% by moles of a fluorinated monomer selected from tetrafluoroethylene, chlorotrifluoroethylene, or their mixtures; (C) from 0.1 to 10% by moles with respect to the total amount of monomers (A) and (B), of a fluorodioxol having the formula: <CHEM> wherein RF is a perfluoroalkyl having from 1 to 5 carbon atoms; X1 and X2, equal to or different from each other, are -F or -CF3; Z is selected from -F, -H, -Cl.
Patent AT-E212830-T1 (AT)
Inventor: HERBERT PAUL F
IPC: A61K9/50
Filed: 1994-11-18
Granted: 2002-02-15
Abstract: A process for preparing biodegradable microparticles comprising a biodegradable polymeric binder and a biologically active agent. A first phase, comprising the active agent and the polymer, and a second phase are combined under the influence of mixing means to form an emulsion and microparticles are isolated from the emulsion. A blend of at least two substantially non-toxic solvents, free of halogenated hydrocarbons, is used to dissolve or disperse the agent and dissolve the polymer.
Patent AT-E175471-T1 (AT)
Inventor: RASO ROLAND
IPC: F02B53/00
Filed: 1995-02-16
Granted: 1999-01-15
Abstract: PCT No. PCT/FR95/00185 Sec. 371 Date Dec. 24, 1996 Sec. 102(e) Date Dec. 24, 1996 PCT Filed Feb. 16, 1995 PCT Pub. No. WO95/22684 PCT Pub. Date Aug. 24, 1995A machine with rotary pistons having an engine unit with a cylindrical chamber, the engine having two rotors coaxially mounted in the cylindrical chamber. The first rotor is continuously rotationally driven. The second rotor is intermittently rotationally driven in a same direction as the first rotor. A transmission is connected between the rotors. This transmission includes an engaging member having a non-return mechanism. The non-return mechanism includes a first element fixed to the engine unit and a second element in engagement with the second rotor. The first and second elements are cooperative with each other through an angular blocking during the explosion and intake phase of the engine unit. The hydraulic pump has a rotor coupled to the first rotor and a stator coupled to the engine unit. A hydraulic motor is coupled to the second rotor and connected to the hydraulic pump by a hydraulic circuit. At least one valve is operatively connected to the engaging member. The valve serves to partially or totally open the hydraulic circuit during one phase of the engine unit and closes the hydraulic circuit during another phase of the engine unit. The opening or closing of the hydraulic circuit will engage or disengage the second rotor with respect to the first rotor.
Patent AT-E203755-T1 (AT)
Inventor: PORRVIK INGRID
IPC: C08J9/28
Filed: 1995-05-10
Granted: 2001-08-15
Abstract: PCT No. PCT/SE95/00516 Sec. 371 Date Dec. 12, 1996 Sec. 102(e) Date Dec. 12, 1996 PCT Filed May 10, 1995 PCT Pub. No. WO95/31485 PCT Pub. Date Nov. 23, 1995A method of producing open porous spherical particles by polymerizing monovinyl monomers and divinyl monomers and/or polyvinyl monomers (cross-linkers) in an emulsion with the aid of an initiator. The method is characterized by the steps of (i) preparing a w/o/w emulsion which comprises an aqueous phase having emulsified therein droplets which contain a water-in-oil emulsion, wherein the oil phase in the droplets includes vinyl monomers and an emulsifier which provides an inverse emulsion and the droplets have a diameter smaller than 2,000  mu m, and wherein the total amount of water is between 75-99% (w/w); and (ii) thereafter initiating polymerization and isolating the particles, optionally after sieving, from the reaction mixture after the polymerization process. A population of open spherical porous polymer particles which have a diameter within the range of 50  mu m-2,000  mu m and include a pore system comprising (a) spherical hollows whose diameters are <+E,fra 1/9+EE  of the particle diameter; and (b) connecting pores whose opening diameters to the spheres and on the particle surfaces are about +E,fra 1/10+EE -+E,fra 1/3+EE  of the diameter of the spheres.
Patent AT-E329616-T1 (AT)
Inventor: MURTAUGH MICHAEL P
IPC: G01N33/569
Filed: 1995-08-04
Granted: 2006-07-15
Abstract: A nucleotide sequence is provided for the VR-2332 virus, which is capable of causing Porcine Reproductive and Respiratory Syndrome. The nucleotide sequence includes protein coding regions that are inserted into recombinant vectors for the host expression of viral proteins according to a variety of vaccination techniques. Diagnostic assays utilize fragmentary sequences or oligonucleotides to selectively identify the VR-2332 nucleic acids by hybridization or PCR amplification reactions that distinguish VR-2332 nucleotide sequences from other PRRS-causative viruses which are immunologically distinct from VR-2332.
Patent AT-E213623-T1 (AT)
Inventor: BOLOGNA WILLIAM JOSEPH
IPC: A61P31/00
Filed: 1995-10-06
Granted: 2002-03-15
Abstract: The present invention provides a composition and use of a composition comprising a bioadhesive cross-linked polycarboxylic acid polymer formulation that enables the use of relatively low mounts of anti-STD infectants, such as N-9, to be used to prevent infection by STDs without causing the irritation to genital tissue that often accompanies higher doses of anti-STDs. The bioadhesive polymer maintains greater contact between the anti-STD agent and the infectant for a much greater period of time, enabling a lower concentration to act longer on the infectant, when compared to currently-available commercial applications containing N-9. Such delivery will enable a safe and non-irritating decrease in the risk of infection with STDs, including HIV.
Patent AT-E202399-T1 (AT)
Inventor: FEIL EUGEN
IPC: E04D1/36
Filed: 1996-12-03
Granted: 2001-07-15
Abstract: The roof has a wind excluding membrane of overlapping rolls of flexible sheet materials unwound in parallel strips (5,6,7) across the roof boarding (2). The sheets are laid to cover the transverse roofing laths and held on to the laths without penetration by the clipping action of a decking piece (8). The decking pieces are U-shaped and are sized to fit on top of and along the length of the laths and clamp on to lathe sides. The overlapping edges of the strips of sheet material are securely held and protected during installation of the tiles (4) and completion of the roof construction.
Patent AT-E272919-T1 (AT)
Inventor: MEURISSE WIM POL
IPC: H04Q3/00
Filed: 1996-03-20
Granted: 2004-08-15
Abstract: As long as a queuing network node (Q) is not congested, it returns to the source terminals (S1, S2, S3, S4) transmitting data packets through this queuing network node (Q), upper packet rate values (ER) which are proportional to the actual packet rate values (CCR). The transmit rate of a source terminal (S1, S2, S3, S4) upon receipt of the upper packet rate value (ER), is controlled so that it stays below this upper packet rate value. In this way, the queuing network node (Q) allows its aggregate input rate to increase in a controlled, smooth way and does not rely on the sources (S1, S2, S3, S4) themselves. Once the queuing network node (Q) gets congested a fair share algorithm is used to determine which source terminals have to decrease their transmit rates and which source terminals are allowed to further increase their transmit rates. <IMAGE>
Patent AT-E183558-T1 (AT)
Inventor: PAVAN FEDERICO
IPC: C25D3/58
Filed: 1996-06-27
Granted: 1999-09-15
Abstract: A process for electrolytic codeposition of copper and zinc on a metal element wherein the electrolytic bath consists of an aqueous solution of at least a bivalent copper salt, at least a zinc salt and an alkali pyrophosphate, and an amino acid compound of formula <CHEM> wherein Y, R1, and R2 have the meanings shown in the description, or an acid-addition salt of said amino acid compound, at a temperature of from 40 DEG C to 55 DEG C.
Patent AT-E332513-T1 (AT)
Inventor: MENEZES EDGAR V
IPC: A61F2/16
Filed: 1996-05-03
Granted: 2006-07-15
Abstract: A multifocus, concentric annular ring lens wherein one of the front and back surfaces of the lens defines a central area comprising a circular disc having a spherical surface corresponding to a basic prescription Rx spherical distance optical power. A plurality of annular rings surround the central area and have alternating spherical near and distance optical powers, and at least one intermediate optical power annular ring. The immediate optical power annular ring is located in the middle or outer region of the lens optic zone, and its optical power is intermediate to the distance and near optical powers, to provide visual acuity at intermediate distances. The intermediate optical power annular ring can be placed anywhere in the middle or outer region of the lens optic zone, and can be the second annular ring from the outer edge of the lens optic zone, or can be the outermost annular ring which defines the outer circumference of the lens optic zone. The lens can be a contact lens to be worn on the cornea of the eye, such as a soft hydrogel contact lens, or can be an intraocular lens.
Patent AT-E215594-T1 (AT)
Inventor: RICHARDS JAMES L
IPC: C09J175/00
Filed: 1996-07-04
Granted: 2002-04-15
Abstract: A one-part, moisture-cure urethane adhesive composition contains between 1 and 10 phr  gamma -butyrolactone which acts as a moisture diffusion agent, thereby promoting a more rapid cure.
Patent AT-E182325-T1 (AT)
Inventor: LANGLOIS MICHEL
IPC: A61K31/16
Filed: 1996-04-11
Granted: 1999-08-15
Abstract: Tricyclic amides of formulae (A1) to (A4), their enantiomers and diastereoisomers, and their salts with bases are new. R1-R6 = H, halo, OH, Ra or ORa; Ra = alkyl opt. substd by one or more halo; alkenyl; alkynyl; cycloalkyl; cycloalkylalkyl; opt. substd. aryl; or opt. substd. arylalkyl; X1 = S, O, C(R5)=C(R6), C(R5)(R5)C(R6)(R6'), C(R5)(R5')C(R6)=, C(R5)(R5') or N(R14); R5', R6' = as for R1-R6; R14 = H, alkyl, opt. substd. aryl, opt. substd. arylalkyl; the dotted bond indicates that it may be single or double; Y = C(R9)(R10); R9, R10 = H, alkyl, or alkoxy; n = 1-3; R7 = H or R7'; R7' = alkyl, opt. substd. aryl or opt. substd. arylalkyl; R8 = COR11 or CSR11; R11 = R12 or NH(R13); R12, R13 = H, alkyl, haloalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, opt. substd. aryl or opt. substd. arylalkyl; with the provisos that (a) (I) is not N-(4-methyl- 1H-2,3-dihydro phenalen-2-yl) acetamide, and (b) if X1 = NH or -N(CH3), then R1 = neither H nor halo; alkyl, alkoxy = 1-6C; alkenyl, alkynyl = 2-6C; cycloalkyl = 3-8C; aryl = naphthyl, phenyl or pyridyl; and the opt. substits. on aryl and arylalkyl = halo, alkyl, haloalkyl, alkoxy, or OH.
Patent AT-E245989-T1 (AT)
Inventor: EIBL JOHANN
IPC: G01N33/569
Filed: 1996-05-06
Granted: 2003-08-15
Abstract: The invention relates to a medicament containing one or more plasma derivatives as the active or auxiliary agent, in which the basic material or the intermediate products arising during the production of the plasma derivatives exert no viral stress on one or more differently proliferable haematogenic viruses or such an effect not exceeding a defined limit. The basic material or intermediate product for producing the final plasma derivative of which the quality is thus assured is subsequently subjected to at least one essential viral enrichment or inactivation step. The invention also describes a process for producing the medicament and the production of assured-quality basic materials or intermediate products.
Patent AT-E228851-T1 (AT)
Inventor: VOSE JOHN R
IPC: A61K39/00
Filed: 1996-05-02
Granted: 2002-12-15
Abstract: Vaccine for protecting humans against Bordetella pertussis infection comprises pertussis toxoid (I), filamentous haemagglutinin (II), pertactin (III) and agglutinogens (IV) of B. pertussis in relative amts. able to confer protection to >= 70% of an at-risk population. A single dose is 5-30 mu g (I) and (II), 3-15 mu g (III) and 1-10 mu g (IV), all expressed as nitrogen contents, esp. 10 mu g (I) and 5 mu g (II) or 20 mu g each of these, plus 5 mu g (III) and 3 mu g (IV). Vaccines are administered by subcutaneous or intramuscular injection. (IV) comprises fimbrial agglutinogens (Agg) 2 and 3 (pref. at ratio 1.5-2:1) but is free of Agg 1. These may also include diphtheria toxoid, pref. at 15 Lfs, and tetanus toxoid, pref. at 5 Lf, opt. also other non-Bordetella antigens. They can also include an adjuvant, specifically alum.
Patent AT-E201341-T1 (AT)
Inventor: HOLMBERG ANDERS
IPC: B22D11/10
Filed: 1996-08-16
Granted: 2001-06-15
Abstract: Thin metal strips, for example wide carbon steel strips, are cast in a single belt machine. The width of the molten metal on the belt is defined by side dams (12, 13) on the belt (11). The side dams have inwardly directed surfaces against the molten metal which makes the surface of the molten metal even also at its edges.
Patent AT-E329047-T1 (AT)
Inventor: REISS BERND
IPC: C12N15/09
Filed: 1996-08-30
Granted: 2006-06-15
Abstract: The present invention relates to a novel process for the production of transgenic organisms or transgenic cells, to transgenic orgaisms or transgenic cells obtainable by the process of the present invention, to the use of vectors comprising DNA encoding a recombination promoting enzymes for curing impairments caused by environmental influences in plants or plant cells and for gene therapy in mammals or mammalian cells, and to novel vectors.